Killing Cancer Cells: Pictures start Moving


In Cancer Immunotherapy, the development of promising anti-cancer therapeutics requires a screening system that measures the efficiency of effector cells when attacking the target. For evaluation of constructs, important parameters are individual kinetics and specificity of target killing as well as persistance in the tissue.

Common Cytotoxicity assays like release assays have their drawbacks. New technologies are emerging.

This article compares current approaches: How CAR-T Cells Kill Cancer: Pictures start Moving

Find out how xCELLigence directly monitors and quantifies cell-mediated cytotoxicity: www.ols-bio.de/car-t

 
 

Passende Artikel

xCELLigence MP

The highly flexible System for High Throughput and/or Multi User Applications xCELLigence MP: Multi-Plate system for 6 x 96-well E-Plates. Highest flexibility for labs with really high sample throughput, or simultaneous use by several different users. Run your Real Time Cell Analysis (RTCA) fully automated and label-free to produce data of highest quality and integrity. The software covers a broad application range and incorporates a very...

Preis auf Anfrage

2801003

xCELLigence SP

Space saving 96-well Single-Plate System xCelligence SP: Single plate system for 96-well E-Plates. Small foot print, minimum space consumption inside the incubator. Run your Real Time Cell Analysis (RTCA) fully automated and label-free to produce data of highest quality and integrity. A broad application range and full kinetic data recorded make this technology far superior to any conventional assays. Get a wealth of information on the...

Preis auf Anfrage

2801000

 
 

Kommentar schreiben

 

Die mit einem * markierten Felder sind Pflichtfelder.